EFFICIENCY OF ANTI-INFLAMMATORY THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS ACCORDING TO THE RESULTS OF A PROSPECTIVE FOLLOW-UP STUDY

In accordance  with the Ankylosing Spondylitis Assessments (ASAS) International Working Group guidelines, tumor necrosis factor-α  inhibitors are recommended in patients with ankylosing spondylitis (AS) refractory to at least two nonsteroidal  anti-inflammatory drugs (NSAIDs)  and in those with the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	T. A. Raskina, O. S. Malyshenko, O. A. Pirogova, M. A. Volykova
Formato:	Artigo
Idioma:	Russo
Publicado em:	IMA PRESS LLC 2016-09-01
Colecção:	Научно-практическая ревматология
Assuntos:	ankylosing spondylitis men nonsteroidal anti-inflammatory drugs infliximab
Acesso em linha:	https://rsp.mediar-press.net/rsp/article/view/2253
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!